Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events: A 1-Year Follow-up.
Neurology. 2023 Jan 24;100(4):e408-e421. doi: 10.1212/WNL.0000000000201426. Epub 2022 Oct 18.
Neurology. 2023.
PMID: 36257718
Free PMC article.
Probing 4-(diethylamino)-salicylaldehyde-based thiosemicarbazones as multi-target directed ligands against cholinesterases, carbonic anhydrases and α-glycosidase enzymes.
Hashmi S, Khan S, Shafiq Z, Taslimi P, Ishaq M, Sadeghian N, Karaman HS, Akhtar N, Islam M, Asari A, Mohamad H, Gulçin İ.
Hashmi S, et al.
Bioorg Chem. 2021 Feb;107:104554. doi: 10.1016/j.bioorg.2020.104554. Epub 2020 Dec 15.
Bioorg Chem. 2021.
PMID: 33383322
Against the physiologically dominant isoform hCA II, the novel compounds demonstrated K(i)s varying from 323.04 56.88 to 991.62 77.26 nM. Also, these novel 4-(diethylamino)-salicylaldehyde based thiosemicarbazones (3a-p) effectively inhibited AChE, with Ki values in …
Against the physiologically dominant isoform hCA II, the novel compounds demonstrated K(i)s varying from 323.04 56.88 to 991.6 …
Item in Clipboard
Synthesis, bioactivity and binding energy calculations of novel 3-ethoxysalicylaldehyde based thiosemicarbazone derivatives.
Ishaq M, Taslimi P, Shafiq Z, Khan S, Ekhteiari Salmas R, Zangeneh MM, Saeed A, Zangeneh A, Sadeghian N, Asari A, Mohamad H.
Ishaq M, et al.
Bioorg Chem. 2020 Jul;100:103924. doi: 10.1016/j.bioorg.2020.103924. Epub 2020 May 12.
Bioorg Chem. 2020.
PMID: 32442818
Against the physiologically dominant isoform hCA II, the novel compounds demonstrated K(i)s varying from 110.54 14.05 to 444.12 36.08 nM. Also, these novel derivatives (3a-r) effectively inhibited AChE, with Ki values in the range of 385.38 45.03 to 983.04 104.64 nM …
Against the physiologically dominant isoform hCA II, the novel compounds demonstrated K(i)s varying from 110.54 14.05 to 444.1 …
Item in Clipboard
Cite
Cite